Padmanabh P. Bhatt - 06 Jan 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. VP of IP, CSO
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
06 Jan 2023
Net transactions value
-$5,354
Form type
4
Filing time
09 Jan 2023, 16:00:40 UTC
Previous filing
02 Dec 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $1,589 +174 +11% $9.13 1,818 06 Jan 2023 Direct F1
transaction SUPN Common Stock Sale $6,943 -174 -9.6% $39.90 1,644 06 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Options Exercise $0 -174 -1.7% $0.000000 9,826 06 Jan 2023 Common Stock 174 $9.13 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted September 8, 2022.
F2 The option vested in four equal annual installments beginning on March 3, 2016.